CASE REPORT

Hippokratia 2017, 21(4):191-193

Kimiskidis VK1, Papaliagkas V1, Kazis DA2,Geroukis T3, Bostantjopoulou S2
1
Laboratory of Clinical Neurophysiology, AHEPA University Hospital, 2Department of Neurology III, G.Papanikolaou Hospital, Aristotle University of Thessaloniki, 3Department of Radiology, G.Papanikolaou Hospital, Thessaloniki, Greece

Abstract

Background: Previous transcranial magnetic stimulation (TMS) studies in patients with tropical spastic paraparesis (TSP) have focused on central motor conduction time measurements while other TMS parameters remained unexplored. From a neuroradiological point of view, pyramidal tract involvement with magnetic resonance imaging and diffusion tensor imaging (DTI) has been rarely reported in TSP.  Accordingly, the present study investigated the mean threshold (MT) and silent period (SP) as well as DTI measurements in TSP.

Case description: A 35-year-old female patient presented with a 15-year history of spastic paraparesis with minimal upper-limb involvement. Serum and cerebrospinal fluid samples were positive for HTLV-I. TMS was performed with a figure-of-eight coil (recording, abductor hallucis and first dorsal interosseous muscles). Thr was measured at 1 % steps. SPs were elicited at 5 % increments from 0 to 100 % maximum stimulus intensity (SI), and data were used to construct a stimulus/response (S/R) curve of SI vs SP. The resulting S/R curves were fitted to a Boltzmann equation and statistically compared to control data. Voxel-based DTI analysis was performed with SPM 99. Corticospinal tractography was based on diffusion tensor data. The TMS examination disclosed that MT was significantly increased (54.5 ± 6.36 % vs 41.08 ± 7.85 % in a group of 82 controls, p=0.019). The patient’s SP S/R curve had significantly reduced Max values compared to 13 age-matched controls (160.4 ± 0.91 ms vs 228.36 ± 38.69 ms, p <0.001). Fractional anisotropy was decreased in a cluster of voxels corresponding to the area of the pyramidal tract (0.388 ± 0.015 vs 0.506 ± 0.02 in 20 age-matched controls, p <0.001).

Conclusion: The described results provide novel neurophysiological and imaging evidence for central motor pathways malfunctioning in TSP. HIPPOKRATIA 2017, 21(4): 191-193.

Read PDF

Key words: Transcranial magnetic stimulation, tropical spastic paraparesis, diffusion tensor imaging

Corresponding author: Vasilios K.Kimiskidis, Professor of Neurology-Clinical Neurophysiology, Laboratory of Clinical Neurophysiology, AHEPA University Hospital, Aristotle University of Thessaloniki, 1 St.Kiriakidi str., 54636, Thessaloniki, Greece, tel: +302310994667, fax: +302310994670, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Introduction

Tropical spastic paraparesis (TSP) or human T-cell lymphotropic virus-I (HTLV-I)-associated myelopathy (HAM) is an uncommon neurological manifestation of infection with the HTLV-I virus1. The latter is endemic in the equatorial areas, the southern part of Japan, and parts of South America but can also affect human immunodeficiency virus (HIV)-infected patients and drug users.

Transcranial magnetic stimulation (TMS) studies in TSP provided evidence for altered central motor conduction particularly along the thoracic spinal cord2,3. Other TMS parameters, however, have not been investigated and it is currently unknown whether brain excitatory and inhibitory processes are affected as well. Brain involvement in TSP was suggested by magnetic resonance imaging (MRI) studies revealing subcortical and periventricular white matter lesions4,5. Moreover, Vilchez et al6 employed diffusion tensor imaging (DTI) to study TSP patients and observed significant spinal cord atrophy and reduced fractional anisotropy (FA) values.

The present case study aims to extend the previous TMS findings in TSP and also to perform DTI analysis and corticospinal tractography.

Case report

A 35-year-old Caribbean female patient presented with a 15-year history of spastic paraparesis with minimal upper-limb involvement. On examination, muscle strength was mildly reduced in the upper and particularly the lower limbs (grade 4+/5 and 4-/5 of the MRC muscle scale, respectively). Laboratory investigations revealed positive serum and cerebrospinal fluid samples for HTLV-I.

TMS was performed with a Magstim 200 stimulator (Magstim, Dyfed, Wales) and motor evoked potentials (MEPs) were recorded from the first dorsal interosseous and abductor hallucis muscles. For upper limbs, stimulation was performed with a 70-mm diameter figure-of-eight coil (Magstim type 9925), optimally located and orientated for the excitation of the motor hand area. For lower limbs, a double cone coil (Magstim type 9902), centered over the vertex, was employed.

Corticomotor threshold was defined at rest in 1 % steps using the method of Mills and Nithi which determines two stimulus intensity levels designated lower (LT) and upper (UT) threshold. Briefly, LT corresponds to the highest intensity which evokes MEPs with a probability of zero whereas UT is the lowest intensity which evokes MEPs with a probability of unity. Mean threshold (MT) is the arithmetic mean of UT and LT.

Silent period (SP) stimulus-response (S/R) curves were constructed and analyzed as previously described7. Briefly, S/R curves of SP duration against stimulus intensity (SI) were constructed using a wide range of SIs (from 5 to 100 % maximum SI in 5 % increments). At each SI, four SPs were obtained, and the average value of SP duration was used to construct the S/R curve. Stimuli of different intensity were applied in random order to avoid serial order effects.  As previously shown, the resulting S/R curves are sigmoidal7. Therefore, the Boltzmann equation was used to fit these data by the Levenberg-Marquard non-linear least-mean-square algorithm. The Boltzmann function is given by the equation:

Y =Min + (Max - Min)/1 + exp (V50 - X /Slope)

where Y is SP duration, and X is SI, Min and Max are the minimum and maximum values of SP duration, V50 is the SI at which SP duration is halfway between Min and Max, and slope is a measure of the steepness of the curve.

Corticospinal tractography was based on diffusion tensor data obtained with a 1.5 T MRI scanner in 20 healthy age-matched controls. Voxel-based DTI analysis was performed with the statistical parametric mapping 99 (SPM’99).

Statistical analysis was performed using the IBM SPSS Statistics for Windows, version 23.0 (IBM SPSS, IBM Corp., Armonk, NY, USA). Statistical significance was set at p <0.05. The patient’s data were compared with the control group, studied with identical methods8 using the SINGLIMS_ES test9.

Measurement results

The patient’s UT, MT, and LT were significantly higher compared to a previously described healthy control group (a convenient sample comprising 82 hospital personnel and relatives thereof)8. MT for instance was 54.5 ± 6.36 % versus 41.08 ± 7.85% in the controls (p =0.019).

The central motor conduction time (CMCT) to upper limbs was within normal limits (6.61 ± 0.41 ms vs 5.7 ± 1.1 ms in controls, p >0.05). In contrast, CMCT to lower limbs was markedly prolonged (17.95 ± 3.11 ms vs 11.9 ± 1.7 ms, p <0.001) and lower limb MEPs were dispersed and of low amplitude.

The patient’s SP S/R curve was significantly altered. Its Max value was 160.4 ± 0.91 ms vs 228.36 ± 38.69 ms in a subgroup (n =13 age-matched controls) of the above-mentioned control group (p <0.001) and V50 was 60.43 ± 1.23 vs 51.03 ± 0.57 (p <0.001) whereas slope was not significantly different (10.32 ± 0.94 vs 10.09 ± 0.46, p >0.05) (Figure 1).

Figure 1: The silent period (SP) stimulus-response (S/R) curves of the reported patient (■) and the control group (▲). SP: silent period, SI: stimulus intensity.

FA was decreased in a cluster of voxels corresponding to the area of the pyramidal tract [0.388 ± 0.015 vs 0.506 ± 0.02 in a subgroup (n =20 age-matched controls) of the abovementioned control group, p <0.001] (Figure 2).

Figure 2: Corticospinal tractography of the reported patient with tropical spastic paraparesis compared to controls. CST: corticospinal tractography.

Discussion

The present study provides novel neurophysiological and imaging evidence for central motor pathways malfunctioning in TSP. The previously reported prolongation of CMCT to lower limb muscles was confirmed. It was additionally shown, however, that corticomotor threshold to upper limb muscles is increased and the inhibitory phenomenon of SP is markedly altered. These latter novel findings imply that brain excitatory and inhibitory mechanisms are involved in TSP. The pathophysiological substrate of these findings is unclear. A neuropathological study indicated that inflammatory brain changes occur in the area between the cerebral cortex and the underlying white matter10. Therefore, they are strategically located so as to interfere with intracortical circuits modulating motor cortex excitability.

DTI revealed degradation of the corticospinal tract, in line with Vilchez et al6. A decrease in FA would be anticipated to occur in cases where axonal degeneration predominates. It should be noted that the essential histopathological changes in TSP include both demyelination (which explains the aforementioned CMCT prolongation) as well as axonal degeneration. For instance, a recent study of amyloid-precursor protein, a marker for impairment of fast axonal transport, in the spinal cords of TSP patients indicated that axonal damage might be a primary phenomenon in the pathogenesis of TSP rather than being secondary to demyelination11. Similar axonal changes may possibly explain the pyramidal tract degeneration revealed by the presented DTI data.

It could be argued that the observed findings are an epiphenomenon, resulting from longstanding retrograde degeneration, rather than a direct reflection of the underlying TSP pathophysiology. Unfortunately, both the rarity of the entity under study and the cross-sectional character of our investigation preclude the possibility of clarifying this point. Accordingly, this issue remains to be addressed in properly designed longitudinal assessments.

Conflict of interest

The authors report no relevant conflict of interest and no funding support.

References

1. Levin MC, Jacobson S. HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP): a chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system. J Neurovirol. 1997; 3: 126-140.
2. Waddy H, Claus D, Murray NMF, Rudge P. Central motor conduction studies in tropical spastic paraparesis (TSP). Electroenceph Clin Neurolphysiol. 1990; 75: S159-S160.
3. Young RE, Morgan OS, Forster A. Motor pathways analysis in HAM/TSP using magnetic stimulation and F-waves. Can J Neurol Sci. 1998; 25: 48-54.
4. Kreeger L, Gross M, Nieman E. Magnetic resonance imaging in an HTLV-I antibody positive patient with tropical spastic paraparesis. J Neurol Neurosurg Psychiatry. 1988. 51: 999.
5. Bagnato F, Butman JA, Mora CA, Gupta S, Yamano Y, Tasciyan TA, et  al. Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis. J Neurovirol.  2005; 11: 525-534.
6. Vilchez C, Gonzalez-Reinoso M, Cubbison C, Perez-Then E, Roa P, Martínez A, et al. Atrophy, focal spinal cord lesions and alterations of diffusion tensor imaging (DTI) parameters in asymptomatic virus carriers and patients suffering from human T-lymphotrophic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP). J Neurovirol. 2014; 20: 583-590.
7.  Kimiskidis VK, Papagiannopoulos S, Sotirakoglou K, Kazis DA, Kazis A, Mills KR. Silent period to transcranial magnetic stimulation: construction and properties of stimulus-response curves in healthy volunteers. Exp Brain Res. 2005; 163: 21-31.
8. Kimiskidis VK, Papagiannopoulos S, Sotirakoglou K, Kazis DA, Dimopoulos G, Kazis A, et al. The repeatability of corticomotor threshold measurements. Neurophysiol Clin. 2004; 34: 259-266.
9. Crawford JR, Garthwaite PH, Porter S. Point and interval estimates of effect sizes for the case-controls design in neuropsychology: rationale, methods, implementations, and proposed reporting standards. Cogn Neuropsychol. 2010; 27: 245-260.
10. Aye MM, Matsuoka E, Moritoyo T, Umehara F, Suehara M, Hokezu Y, et al. Histopathological analysis of four autopsy cases of HTLV-I-associated myelopathy/tropical spastic paraparesis: inflammatory changes occur simultaneously in the entire central nervous system. Acta Neuropathol. 2000; 100: 245-252.
11. Umehara F, Hagiwara T, Yoshimura M, Higashi K, Arimura K. Enlarged, multifocal upper limb neuropathy with HTLV-I associated myelopathy in a patient with chronic adult T-cell leukemia.  J Neurol Sci. 2008; 266: 167-170.